Skip to main content

ADA 2025: the 85th Scientific Sessions

ADA 2025: the 85th Scientific Sessions

20–23 June | Chicago

The American Diabetes Association’s 85th Scientific Sessions will provide the latest updates in diabetes research, prevention, and care. Key topics will include the quality and accessibility of diabetes care, and technology innovations. Register to be notified when we publish the latest news from the meeting.

Diabetes & Endocrinology Update

Covering the latest advances and keeping your practice up to date. Receive newsletters personally curated for the busy specialist.

Stay up to date with more from Springer Medicine

Podcast

Episode 19: GLP-1 medicines - past, present, and future

We talk with Prof. Daniel Drucker about the early work on GLP-1 medicines for the treatment of diabetes, how they are now impacting the lives of people living with obesity, and their potential use for many other indications.

» Listen now

At a glance: The ONWARDS trials

Novel weekly insulin icodec in people with diabetes.

Video

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.
 

CME & eLearning

T2D & CKD: putting evidence into practice (Link opens in a new window)

Vodcasts providing expert guidance on the multidisciplinary approach to chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Health+ IME

Rethinking adolescent obesity (Link opens in a new window)

Incidence of adolescent obesity is at an all-time high. Discover the unique challenges faced by adolescents with obesity, and learn effective strategies to help young people overcome this disease.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Health+ IME

Advanced glucose and ketone monitoring for better diabetes management (Link opens in a new window)

AMA PRA Category 1 Credits

Dive into three expert-led programs detailing the latest updates on continuous glucose monitoring and continuous ketone monitoring to elevate care for your patients with diabetes.

Supported by:
  • Abbott
Developed by: Springer Health+ IME